Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2
Sponsor: Johnson & Johnson Vision Care, Inc.
Listed as NCT03701516, this NA trial focuses on Myopia and remains completed. Sponsored by Johnson & Johnson Vision Care, Inc., it has been updated 12 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2022 — Jul 2024 [monthly]
Completed NA
-
Apr 2022 — May 2022 [monthly]
Completed NA
-
Jan 2021 — Apr 2022 [monthly]
Completed NA
▶ Show 7 earlier versions
-
May 2020 — Jan 2021 [monthly]
Completed NA
-
Feb 2020 — May 2020 [monthly]
Completed NA
-
Jan 2020 — Feb 2020 [monthly]
Completed NA
-
Jul 2019 — Jan 2020 [monthly]
Completed NA
-
Feb 2019 — Jul 2019 [monthly]
Completed NA
Status: Recruiting → Completed
-
Dec 2018 — Feb 2019 [monthly]
Recruiting NA
-
Nov 2018 — Dec 2018 [monthly]
Recruiting NA
First recorded
Sep 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Johnson & Johnson Vision Care, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .